These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17881868

  • 1. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
    Sukasem C, Churdboonchart V, Sirisidthi K, Riengrojpitak S, Chasombat S, Watitpun C, Piroj W, Tiensuwan M, Chantratita W.
    Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J, Yue J, Wu S, Yan Y.
    Arch Virol; 2007 Sep; 152(10):1799-805. PubMed ID: 17619115
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP, Queiroz BB, Stefani MM.
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [Abstract] [Full Text] [Related]

  • 4. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C, Churdboonchart V, Sukeepaisarncharoen W, Piroj W, Inwisai T, Tiensuwan M, Chantratita W.
    Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
    [Abstract] [Full Text] [Related]

  • 5. Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
    Delaugerre C, Morand-Joubert L, Chaix ML, Picard O, Marcelin AG, Schneider V, Krivine A, Compagnucci A, Katlama C, Girard PM, Calvez V.
    Antivir Ther; 2004 Jun; 9(3):415-21. PubMed ID: 15259904
    [Abstract] [Full Text] [Related]

  • 6. Short communication. Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa).
    Maslin J, Rogier C, Caron M, Grandadam M, Koeck JL, Nicand E.
    Antivir Ther; 2005 Jun; 10(7):855-9. PubMed ID: 16312182
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC, Chen JH, Wong KH, Chan K, Cheng VC, Lam HY, Lee SS, Zheng BJ, Yuen KY.
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [Abstract] [Full Text] [Related]

  • 8. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.
    Antivir Ther; 2007 Apr; 12(1):123-9. PubMed ID: 17503757
    [Abstract] [Full Text] [Related]

  • 9. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [Abstract] [Full Text] [Related]

  • 10. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.
    Sukasem C, Churdboonchart V, Chasombat S, Kohreanudom S, Watitpun C, Pasomsub E, Piroj W, Tiensuwan M, Chantratita W.
    Infection; 2007 Apr; 35(2):81-8. PubMed ID: 17401711
    [Abstract] [Full Text] [Related]

  • 11. Antiretroviral drug resistance and resistance testing.
    Gallant JE.
    Top HIV Med; 2007 Apr; 13(5):138-42. PubMed ID: 16377851
    [Abstract] [Full Text] [Related]

  • 12. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
    Zhang X, Li S, Li X, Li X, Xu J, Li D, Ruan Y, Xing H, Zhang X, Shao Y.
    AIDS; 2007 Dec; 21 Suppl 8():S59-65. PubMed ID: 18172393
    [Abstract] [Full Text] [Related]

  • 13. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V, Ledwaba J, Hunt G, Rakgotho M, Singh B, Makubalo L, Bennett DE, Puren A, Morris L.
    Antivir Ther; 2008 Dec; 13 Suppl 2():101-7. PubMed ID: 18575198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug-resistant mutation patterns in CRF01_AE cases that failed d4T+3TC+nevirapine fixed-dosed, combination treatment: Follow-up study from the Lampang cohort.
    Saeng-aroon S, Tsuchiya N, Auwanit W, Ayuthaya PI, Pathipvanich P, Sawanpanyalert P, Rojanawiwat A, Kannagi M, Ariyoshi K, Sugiura W.
    Antiviral Res; 2010 Jul; 87(1):22-9. PubMed ID: 20382184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
    Nouhin J, Donchai T, Hoang KT, Ken S, Kamkorn J, Tran T, Ayouba A, Peeters M, Chaix ML, Lien TX, Nerrienet E, Ngo-Giang-Huong N.
    Infect Genet Evol; 2011 Jan; 11(1):38-43. PubMed ID: 21094281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.